Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation

Ryo Fukaura; Chiaki Terashima-Murase; Kana Tanahashi; Yoshitaka Sato; Masaaki Kawase; Kohji Kato; Masashi Akiyama

doi:10.1001/jamadermatol.2023.3801

Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation

Ryo Fukaura, Chiaki Terashima-Murase, Kana Tanahashi, Yoshitaka Sato, Masaaki Kawase, Kohji Kato, Masashi Akiyama

School of Biochemistry

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Abstract

Generalized verrucosis (GV) is a rare condition characterized by numerous verrucous skin lesions, potentially affecting the whole skin surface. Often there is an underlying immunodeficiency that predisposes patients to developing systemic human papillomavirus (HPV) infections. Genetic variants have also been implicated, such as in TMC6/TMC8, and this particular subtype of GV is known as epidermodysplasia verruciformis (EV). Here, we report a case of GV that has copresented with 3C syndrome.

Original language	English
Pages (from-to)	1397-1399
Number of pages	3
Journal	JAMA Dermatology
Volume	159
Issue number	12
DOIs	https://doi.org/10.1001/jamadermatol.2023.3801
Publication status	Published - 18 Oct 2023

Keywords

Humans
Dandy-Walker Syndrome
Heart Septal Defects, Atrial
Dietary Supplements
Immunoglobulin G

Access to Document

10.1001/jamadermatol.2023.3801

Handle.net

Persistent link

Cite this

@article{f75f25fd52394d90ad7863354a92fb14,

title = "Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation",

abstract = "Generalized verrucosis (GV) is a rare condition characterized by numerous verrucous skin lesions, potentially affecting the whole skin surface. Often there is an underlying immunodeficiency that predisposes patients to developing systemic human papillomavirus (HPV) infections. Genetic variants have also been implicated, such as in TMC6/TMC8, and this particular subtype of GV is known as epidermodysplasia verruciformis (EV). Here, we report a case of GV that has copresented with 3C syndrome.",

keywords = "Humans, Dandy-Walker Syndrome, Heart Septal Defects, Atrial, Dietary Supplements, Immunoglobulin G",

author = "Ryo Fukaura and Chiaki Terashima-Murase and Kana Tanahashi and Yoshitaka Sato and Masaaki Kawase and Kohji Kato and Masashi Akiyama",

year = "2023",

month = oct,

day = "18",

doi = "10.1001/jamadermatol.2023.3801",

language = "English",

volume = "159",

pages = "1397--1399",

journal = "JAMA Dermatology",

issn = "2168-6068",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation

AU - Fukaura, Ryo

AU - Terashima-Murase, Chiaki

AU - Tanahashi, Kana

AU - Sato, Yoshitaka

AU - Kawase, Masaaki

AU - Kato, Kohji

AU - Akiyama, Masashi

PY - 2023/10/18

Y1 - 2023/10/18

N2 - Generalized verrucosis (GV) is a rare condition characterized by numerous verrucous skin lesions, potentially affecting the whole skin surface. Often there is an underlying immunodeficiency that predisposes patients to developing systemic human papillomavirus (HPV) infections. Genetic variants have also been implicated, such as in TMC6/TMC8, and this particular subtype of GV is known as epidermodysplasia verruciformis (EV). Here, we report a case of GV that has copresented with 3C syndrome.

AB - Generalized verrucosis (GV) is a rare condition characterized by numerous verrucous skin lesions, potentially affecting the whole skin surface. Often there is an underlying immunodeficiency that predisposes patients to developing systemic human papillomavirus (HPV) infections. Genetic variants have also been implicated, such as in TMC6/TMC8, and this particular subtype of GV is known as epidermodysplasia verruciformis (EV). Here, we report a case of GV that has copresented with 3C syndrome.

KW - Humans

KW - Dandy-Walker Syndrome

KW - Heart Septal Defects, Atrial

KW - Dietary Supplements

KW - Immunoglobulin G

U2 - 10.1001/jamadermatol.2023.3801

DO - 10.1001/jamadermatol.2023.3801

M3 - Article (Academic Journal)

C2 - 37851466

SN - 2168-6068

VL - 159

SP - 1397

EP - 1399

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 12

ER -

Generalized Verrucosis on a Background of 3C Syndrome Treated With Subcutaneous IgG Supplementation

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this